ORA, established in 2006, is a recognized world player in the supply of fully automated PET radiopharmaceutical synthesizers (radiochemistry modules) for use in the production of sterile injectable PET drug products. In 2009, using extensive working knowledge and experience gained in PET manufacturing, the NEPTIS® project was launched. The synthesizers are specifically designed and constructed to meet current industry standards and user requirements with its potential future needs also in mind. The robust hardware and advanced software capabilities provide the means to create an unlimited number of individualized radiotracer synthesis applications. Currently, more than 600 NEPTIS® radiopharmaceutical synthesizers in use worldwide in both academic and commercial environments.
| Website | https://www.oraneptis.com |
| Employees | 13 (8 on RocketReach) |
| Industry | Medical Devices |
| Keywords | Nuclear Medicine Technology |
| Competitors | Elekta, Siemens Healthineers, GE HealthCare, Philips, Lantheus, Thermo Fisher Scientific, Bayer, Curium Pharma, Nordion +32 more (view full list) |
Looking for a particular ORA - Optimized Radiochemical Applications employee's phone or email?
ORA - Optimized Radiochemical Applications Questions
Guillaume Villeret is the Technical Director of ORA - Optimized Radiochemical Applications.
8 people are employed at ORA - Optimized Radiochemical Applications.
Top ORA - Optimized Radiochemical Applications Employees
